Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Clinical Nephrology|June 5, 2003
A review of intravenous versus oral vitamin D hormone therapy in hemodialysis patientsR B Mazess, L ElangovanJournal of the American Society of Nephrology : JASN|July 11, 2001
Prevention of metabolic bone disease in the pre-end-stage renal disease settingJ W Coburn, L ElangovanASAIO Journal (American Society for Artificial Internal Organs : 1992)|May 26, 2001
HEMO equilibrated Kt/V goals are difficult to achieve in large male patientsL Elangovan, C S Shinaberger, J A Kraut, et al.Kidney International. Supplement|January 14, 2000
Calcium-sensing receptor and calcimimetic agentsJ W Coburn, L Elangovan, W G Goodman, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 8, 2000
Intermittent doxercalciferol (1alpha-hydroxyvitamin D(2)) therapy for secondary hyperparathyroidismJ M Frazão, L Elangovan, H M Maung, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 3, 2001
Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1alpha-hydroxyvitamin D(2)) in dialysis patients with secondary hyperparathyroidism: a sequential comparisonH M Maung, L Elangovan, J M Frazão, et al.Pageof 1